home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Cardioprotective Action Of Statins

  August, 31 2006 6:37
your information resource in human molecular genetics
The benefits of long-term treatment with statins are well established - they lower cholesterol and prevent heart attacks and strokes. Now a novel beneficial action of statins is reported in a study published online this week in the British Journal of Pharmacology.

The study suggests this action only needs a few days of treatment, is independent of cholesterol lowering and helps the heart to recover after a heart attack.

Following a heart attack, blood does not flow correctly into vessels in the heart, even once they are open again. Increasing the blood flow in these vessels would decrease the area known as "no-reflow" and restore more of the ventricular function. Jing-Lin ZHAO and colleagues demonstrate decreased "no-reflow" and better preservation of ventricular function in animals treated for only two days with a statin called simvastatin. They also identify the mechanism underlying this cardioprotective action, showing that the observed beneficial effects of simavastatin are abolished by blocking the KATP channel in mitochondria.

The results suggest that taking statins long-term not only reduces the likelihood of a heart attack, it could also allow the heart to recover more fully from heart attacks by decreasing the damage done to heart muscle.

Author contact:

Yuejin Yang (Fuwai Heart Hospital, Beijing, China)
Email: realplayone@yahoo.com.cn

(C) British Journal of Pharmacology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.